Merck & Co. Net Income decreased by 243.1% to -$4.24B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 183.5%, from $5.08B to -$4.24B. Over 3 years (FY 2021 to FY 2025), Net Income shows an upward trend with a 11.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher values indicate greater profitability and financial health, directly impacting shareholder value.
The final bottom-line profit of the company after all operating expenses, non-operating expenses, and income taxes have...
The most common metric for evaluating company performance against industry competitors.
net_income| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.55B | $4.57B | $3.76B | $4.31B | $3.94B | $3.25B | $3.02B | $2.82B | -$5.98B | $4.75B | $4.76B | $5.46B | $3.16B | $3.74B | $5.08B | $4.43B | $5.79B | $2.96B | -$4.24B |
| QoQ Change | — | +195.6% | -17.7% | +14.7% | -8.5% | -17.6% | -7.1% | -6.5% | -311.8% | +179.4% | +0.4% | +14.6% | -42.1% | +18.6% | +35.7% | -12.8% | +30.7% | -48.8% | -243.1% |
| YoY Change | — | — | — | — | +155.3% | -28.9% | -19.7% | -34.5% | -251.5% | +46.1% | +68.8% | +191.3% | -33.5% | — | +6.7% | -18.8% | +83.2% | -20.8% | -183.5% |